We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Batches of this medicine are being recalled from the market because of low levels of microbial contamination.
Letters were sent about INOmax (nitric oxide) cylinders and triptorelin (Decapeptyl).
Routine monitoring of liver function now recommended.
Advise patients treated with ingenol mebutate gel to be vigilant for new skin lesions and to seek medical advice immediately should any occur. Use with caution in patients with a history of skin cancer.
First published during the 2019 to 2022 Johnson Conservative government
A signal of increased lower limb amputation (primarily of the toe) in people taking canagliflozin compared with placebo in a clinical trial in high cardiovascular risk patients is currently under investigation.
Pharmaswiss Česka republika s.r.o. (an affiliate of Bausch & Lomb UK Limited) is recalling all unexpired batches of Emerade 500 microgram auto-injectors (also referred to as pens) from patients due to an error in one component of the auto-injector believed...
A summary of letters sent to relevant healthcare professionals in January 2017.
A supply disruption alert was issued by the Department of Health & Social Care (DHSC) on EpiPen and EpiPen Junior; see MHRA advice on extension of use beyond the expiry date for certain batches of EpiPen 300 microgram adrenaline autoinjectors....
(Hospira) Due to pump faults. (MDA/2013/016)
Letter to the Home Secretary on the consideration of oripavine.
(Aurum Pharmaceuticals Limited (trading as Martindale Pharma)) Replaces drug alert issued on 29 April 2013 (EL 13(A)13 Rev 1)
TWO lethal ‘legal highs’ should be controlled as class A substances, recommends the Advisory Council on the Misuse of Drugs (ACMD).
In December 2015, a letter was sent to healthcare professionals regarding Reminyl (galantamine hydrobromide).
Report finds prescription-only medicines are being used to supplement the use of other illicit drugs, including cocaine and heroin.
Accord Healthcare are recalling all unexpired stock of the below products from pharmacies and retail stores as a precautionary measure.
The ACMD have considered the harms associated with the use of O-desmethyltramadol and recommend that O-desmethyltramadol is controlled.
Experts have today called on the government to permanently ban two groups of “legal highs”.
A summary of letters and drug alerts recently sent to healthcare professionals.
A list of all medical device alerts that were archived in July 2015.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).